(Q33906421)

29 July 2017

1 reference

title

Vasopressin receptor antagonism--a therapeutic option in heart failure and hypertension (English)

1 reference

29 July 2017

0 references

1 reference

3

Johnston CI

1 reference

29 July 2017

1

Burrell LM

1 reference

29 July 2017

Risvanis J

2

1 reference

29 July 2017

Naitoh M

series ordinal

4

1 reference

29 July 2017

Balding LC

series ordinal

5

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

published in

Experimental Physiology

1 reference

29 July 2017

volume

85 Spec No

1 reference

29 July 2017

page(s)

259S-265S

1 reference

Osmoregulation of thirst and vasopressin release in severe chronic renal failure.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Vasopressin receptors in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Vascular responses to vasopressin antagonists in man and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Arginine vasopressin (AVP) and AVP-like immunoreactivity in peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Clinical trials of diuretic therapy in heart failure: research directions and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Pressor systems in hypertension and congestive heart failure. Role of vasopressin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Hemodynamic effects of infused arginine vasopressin in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Molecular cloning and sequencing of the gene encoding a sheep arginine vasopressin type 1a receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Anomalous antidiuretic activity of antidiuretic hormone antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Immunoreactive arginine-vasopressin in Brattleboro rat ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Extrahypothalamic expression of the vasopressin and oxytocin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Down-Regulation of Vasopressin VlA Receptor mRNA in Diabetes Mellitus in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate-salt hypertension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1469-445X.2000.TB00031.X

10.1111/J.1469-445X.2000.TB00031.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference